ONE-WAYOngoing theme · still written in the latest filings
Clinical trials and regulatory approval for autologous cultured corneal epithelium
A theme focused on conducting clinical trials for autologous cultured corneal epithelium for limbal stem cell deficiency under a contract development arrangement with NIDEK, while pursuing early approval, discussions on reimbursement listing, and adoption by medical institutions.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps1 helps · 0 hurts · 0 flat